Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study
These findings highlight the potential of S-268019-b to provide broad and robust protection against a range of SARS-CoV-2 variants, addressing a critical challenge in the ongoing fight against coronavirus disease 2019 (COVID-19).
Authors
- Koji Takahashi (ORCID: https://orcid.org/0000-0003-3826-3941)
- Ryo Shinnakasu (ORCID: https://orcid.org/0000-0002-5369-3424)
- Kazuo Yamashita (ORCID: https://orcid.org/0000-0002-7825-4719)
- Shinya Omoto (ORCID: https://orcid.org/0000-0002-2730-3912)
- Akio Suzuki (ORCID: https://orcid.org/0000-0003-2106-2123)
- Takeshi Inoue (ORCID: https://orcid.org/0000-0002-9972-6105)
- Tomohiro Kurosaki (ORCID: https://orcid.org/0000-0002-6352-304X)
- Naomi M. Seki
- Yujiro Kidani
- Xiuyuan Lu (ORCID: https://orcid.org/0000-0002-0784-2871)
- Masaya Fujitani
- Jordan K. Villa (ORCID: https://orcid.org/0000-0002-5052-7551)
- Ayumi Kitano
- R. Shibata (ORCID: https://orcid.org/0000-0002-5276-4358)
- Tommy Terooatea (ORCID: https://orcid.org/0000-0002-7814-3736)
- Mari Ariyasu (ORCID: https://orcid.org/0000-0002-5109-9448)
- Takuhiro Sonoyama (ORCID: https://orcid.org/0009-0005-1734-8446)
- Sho Yamasaki (ORCID: https://orcid.org/0000-0002-5184-6917)
- Takeshi Ishihara (ORCID: https://orcid.org/0000-0001-9175-3072)
- Miwa Aoki
- Shungo Mitsuki
- Takeshi Ota
- Masahiro Takayama
- Satoru Ishida
- Satoshi Iwata
Institutions
- Tokyo Medical University (JP)
- Shionogi (Japan) (JP)
- TagCyx Biotechnologies (Japan) (JP)
- Osaka International University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1550279
- Citations
- 5
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 6.98